Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Incomplete proteasomal degradation of green fluorescent proteins in the context of tandem fluorescent protein timers.

Khmelinskii A, Meurer M, Ho CT, Besenbeck B, Füller J, Lemberg MK, Bukau B, Mogk A, Knop M.

Mol Biol Cell. 2016 Jan 15;27(2):360-70. doi: 10.1091/mbc.E15-07-0525. Epub 2015 Nov 25.


BOR-syndrome-associated Eya1 mutations lead to enhanced proteasomal degradation of Eya1 protein.

Musharraf A, Kruspe D, Tomasch J, Besenbeck B, Englert C, Landgraf K.

PLoS One. 2014 Jan 29;9(1):e87407. doi: 10.1371/journal.pone.0087407. eCollection 2014.


Sipl1 and Rbck1 are novel Eya1-binding proteins with a role in craniofacial development.

Landgraf K, Bollig F, Trowe MO, Besenbeck B, Ebert C, Kruspe D, Kispert A, Hänel F, Englert C.

Mol Cell Biol. 2010 Dec;30(24):5764-75. doi: 10.1128/MCB.01645-09. Epub 2010 Oct 18.


A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros.

Bollig F, Perner B, Besenbeck B, Köthe S, Ebert C, Taudien S, Englert C.

Development. 2009 Sep;136(17):2883-92. doi: 10.1242/dev.031773.


Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.

Klattig J, Sierig R, Kruspe D, Besenbeck B, Englert C.

Mol Cell Biol. 2007 Jun;27(12):4355-64. Epub 2007 Apr 9.


The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter.

Brodbeck S, Besenbeck B, Englert C.

Mech Dev. 2004 Oct;121(10):1211-22.


Low level expression of glycine receptor beta subunit transgene is sufficient for phenotype correction in spastic mice.

Hartenstein B, Schenkel J, Kuhse J, Besenbeck B, Kling C, Becker CM, Betz H, Weiher H.

EMBO J. 1996 Mar 15;15(6):1275-82.

Supplemental Content

Loading ...
Support Center